• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素可刺激人肝癌细胞系Hep G2合成纤溶酶原激活物抑制剂1。

Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2.

作者信息

Alessi M C, Juhan-Vague I, Kooistra T, Declerck P J, Collen D

机构信息

Laboratory of Hematology, CHU Timone, Marseille, France.

出版信息

Thromb Haemost. 1988 Dec 22;60(3):491-4.

PMID:3149048
Abstract

Secretion of plasminogen activator inhibitor 1 (PAI-1) by cultures of human umbilical vein endothelial cells and human hepatocellular cell line Hep G2 was evaluated after insulin stimulation. The secretion of PAI-1 antigen and activity was measured in the conditioned medium and the cellular extracts after incubation of confluent cultures with 1% serum medium for 24 hours. Insulin induced a dose dependent increase of the PAI-1 secretion by Hep G2 cell line. At 10(-8) M a two fold increase of PAI-1 antigen and activity were observed whereas alpha 2 antiplasmin and fibrinogen were not significantly modified. No effect of insulin was observed on PAI-1 antigen and PAI activity production by human endothelial cells whereas endotoxin resulted in a two fold increase in PAI-1 secretion. In recent clinical studies we have demonstrated that the level of plasma insulin correlated with that of PAI-1. Thus we hypothesize that hepatocytes represent a physiological source of plasma PAI-1 which is modulated by plasma insulin level.

摘要

在胰岛素刺激后,对人脐静脉内皮细胞和人肝癌细胞系Hep G2的培养物中纤溶酶原激活物抑制剂1(PAI - 1)的分泌进行了评估。在用1%血清培养基培养汇合培养物24小时后,测量条件培养基和细胞提取物中PAI - 1抗原和活性的分泌。胰岛素诱导Hep G2细胞系分泌PAI - 1呈剂量依赖性增加。在10(-8)M时,观察到PAI - 1抗原和活性增加了两倍,而α2抗纤溶酶和纤维蛋白原没有明显改变。未观察到胰岛素对人内皮细胞产生的PAI - 1抗原和PAI活性有影响,而内毒素导致PAI - 1分泌增加两倍。在最近的临床研究中,我们已经证明血浆胰岛素水平与PAI - 1水平相关。因此,我们推测肝细胞是血浆PAI - 1的生理来源,其受血浆胰岛素水平调节。

相似文献

1
Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2.胰岛素可刺激人肝癌细胞系Hep G2合成纤溶酶原激活物抑制剂1。
Thromb Haemost. 1988 Dec 22;60(3):491-4.
2
Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes.纤溶酶原激活物抑制剂1:在培养的人肝细胞中,胰岛素可增加其生物合成及信使核糖核酸水平。
Thromb Haemost. 1989 Sep 29;62(2):723-8.
3
Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.人肝癌细胞系Hep G2中纤溶酶原激活物抑制剂-1的合成。二甲双胍抑制胰岛素的刺激作用。
J Clin Invest. 1993 May;91(5):2185-93. doi: 10.1172/JCI116445.
4
An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1).一种用于研究内皮纤溶酶原激活物抑制剂(PAI-1)细胞分泌的酶联免疫吸附测定(ELISA)。
Thromb Haemost. 1988 Feb 25;59(1):68-72.
5
Up-regulated expression of plasminogen activator inhibitor-1 in Hep G2 cells: interrelationship between insulin and insulin-like growth factor 1.纤溶酶原激活物抑制剂-1在肝癌细胞系Hep G2中的表达上调:胰岛素与胰岛素样生长因子1之间的相互关系
Thromb Haemost. 1995 Feb;73(2):268-74.
6
Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.人肝细胞和肝癌细胞系Hep G2的条件培养基对纤溶酶原激活剂的抑制作用。
J Lab Clin Med. 1985 Jun;105(6):751-8.
7
Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells is maintained by an autocrine factor.
Thromb Haemost. 1991 Aug 1;66(2):222-5.
8
Clot lysis mediated by cultured human microvascular endothelial cells.培养的人微血管内皮细胞介导的血栓溶解
Thromb Haemost. 1988 Dec 22;60(3):463-7.
9
Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture.凝血酶对培养的人脐静脉内皮细胞中纤溶酶原激活物抑制剂信使核糖核酸的诱导作用。
J Lab Clin Med. 1992 Aug;120(2):222-8.
10
Mediators of induction of augmented expression of plasminogen activator inhibitor type-1 in Hep G2 cells by platelets.血小板诱导Hep G2细胞中纤溶酶原激活物抑制剂-1表达增强的介质。
Thromb Haemost. 1991 Aug 1;66(2):239-45.

引用本文的文献

1
Elevated levels of PAI-1 precede the occurrence of type 2 diabetes mellitus.纤溶酶原激活物抑制剂-1(PAI-1)水平升高先于2型糖尿病的发生。
Diabetol Metab Syndr. 2025 Feb 18;17(1):61. doi: 10.1186/s13098-025-01629-4.
2
Blood PAI-1 and cardiovascular and metabolic risk factors among the middle-aged women from SWAN study.SWAN 研究中中年女性的血液 PAI-1 与心血管和代谢危险因素。
Sci Rep. 2024 Sep 11;14(1):21207. doi: 10.1038/s41598-024-71908-z.
3
HOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity.HOMA-IR作为重度肥胖女性PAI-1水平的预测指标。
Biomedicines. 2024 May 31;12(6):1222. doi: 10.3390/biomedicines12061222.
4
Increased glutamate in type 2 diabetes in the Korean population is associated with increased plasminogen levels.在韩国人群中,2 型糖尿病谷氨酸水平升高与纤溶酶原水平升高有关。
J Diabetes. 2023 Sep;15(9):777-786. doi: 10.1111/1753-0407.13429. Epub 2023 Jun 14.
5
The Association of Acute Phase Proteins in Stress and Inflammation-Induced T2D.应激和炎症诱导的 T2D 中急性期蛋白的相关性。
Cells. 2022 Jul 11;11(14):2163. doi: 10.3390/cells11142163.
6
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target.PAI-1 在糖尿病中的作用:病理生理学及作为治疗靶点的角色。
Int J Mol Sci. 2021 Mar 20;22(6):3170. doi: 10.3390/ijms22063170.
7
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?纤溶酶原激活物抑制剂-1 的综述及其(病理)生理学作用:靶向还是不靶向?
Int J Mol Sci. 2021 Mar 8;22(5):2721. doi: 10.3390/ijms22052721.
8
Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.血栓形成/溶栓平衡作为糖尿病合并冠状动脉疾病患者的心脏治疗决定因素。
J Am Heart Assoc. 2019 Jan 22;8(2):e011207. doi: 10.1161/JAHA.118.011207.
9
Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.甘草酸镁在奥沙利铂诱导的肝损伤模型中具有保肝作用。
Int J Mol Med. 2018 Oct;42(4):2020-2030. doi: 10.3892/ijmm.2018.3787. Epub 2018 Jul 19.
10
A null mutation in protects against biological aging in humans.一个在 中的无效突变可预防人类的生物衰老。
Sci Adv. 2017 Nov 15;3(11):eaao1617. doi: 10.1126/sciadv.aao1617. eCollection 2017 Nov.